DSD-T457

Congenital adrenal hyperplasia (CAH) · 46,XX · DSD-T457

DSD-T457 · Congenital adrenal hyperplasia (CAH) · 2026 · Automated translation

Genes CYP17A1 · Karyotype 46,XX

17α-hydroxylase/17,20-lyase deficiency (46,XX DSD), carrying the novel CYP17A1 variant p.W17*.

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Karyotype

46,XX

Genetics

CYP17A1

Diagnosis

17α-hydroxylase/17,20-lyase deficiency (46,XX DSD), carrying the novel CYP17A1 variant p.W17*.

Follow-up

Not reported in the source (only noted that lifelong replacement is required)

General phenotype

Female phenotype, blood pressure 147/88 mmHg (stage 2 hypertension).

Imaging

Pelvic ultrasound showed a prepubertal uterus with both ovaries visible (left 0.92 mL, right 0.72 mL); adrenal CT showed mild enhancement.

Laboratory findings

K+ 3.31 mmol/L↓; ACTH 59.20 pg/mL↑; LH 50.20 mIU/mL, FSH 148 mIU/mL, progesterone 3.47 ng/mL↑; cortisol 1.95 μg/dL, aldosterone 37.45 pmol/L, estradiol <5 pg/mL, androstenedione 0.02 ng/mL, testosterone <2.50 ng/dL, DHEA-S <15 μg/dL, 17-OHP 0.10 nmol/L↓; PRA 2.17 ng/mL/h.

Management

Lifelong hydrocortisone replacement, with sex hormone replacement from puberty.

Pathology

Not reported in the source

Genetic variants

c.1459_1467delGACTCTTTC, c.50G>A, p.D487_F489del, p.W17*

Evidence level

See source

Clinical history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XX · DSD-T457 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T457?version=v1.4.0